Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias

In the last few years, a lot of publications suggested that disabling cerebellar ataxias may develop through immune-mediated mechanisms. In this consensus paper, we discuss the clinical features of the main described immune-mediated cerebellar ataxias and address their presumed pathogenesis. Immune-mediated cerebellar ataxias include cerebellar ataxia associated with anti-GAD antibodies, the cerebellar type of Hashimoto’s encephalopathy, primary autoimmune cerebellar ataxia, gluten ataxia, Miller Fisher syndrome, ataxia associated with systemic lupus erythematosus, and paraneoplastic cerebellar degeneration. Humoral mechanisms, cell-mediated immunity, inflammation, and vascular injuries contribute to the cerebellar deficits in immune-mediated cerebellar ataxias.

[1]  Xinqing Zhang,et al.  Hashimoto’s encephalopathy mimicking spinocerebellar ataxia , 2011, Journal of Neurology.

[2]  MR spectroscopy in paraneoplastic cerebellar degeneration. , 2013, Journal of neuroradiology. Journal de neuroradiologie.

[3]  I. Kanazawa,et al.  Anti‐GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia , 1999, Muscle & nerve.

[4]  G. Davies-Jones,et al.  Cerebellar ataxia as a possible organ‐specific autoimmune disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[5]  J. Honnorat,et al.  Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. , 2010, Archives of neurology.

[6]  A. García-Zarza,et al.  Cerebellar ataxia associated with neuroendocrine thymic carcinoma and GAD antibodies , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[7]  E. Tongiorgi,et al.  Anti Transglutaminase Antibodies Cause Ataxia in Mice , 2010, PloS one.

[8]  Ikuo Tsunoda,et al.  Purkinje Cell Death After Uptake of Anti-Yo Antibodies in Cerebellar Slice Cultures , 2010, Journal of neuropathology and experimental neurology.

[9]  H. Mitoma,et al.  Presynaptic dysfunction caused by cerebrospinal fluid from a patient with the ataxic form of Hashimoto's encephalopathy , 2014 .

[10]  R. Vandenberghe,et al.  Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis , 2007, Neurology.

[11]  M. Rowley,et al.  Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies. , 2011, Journal of autoimmunity.

[12]  A. Vighetto,et al.  Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. , 2001, Archives of neurology.

[13]  M. Dalakas,et al.  Immunology of stiff person syndrome and other GAD-associated neurological disorders , 2013, Expert review of clinical immunology.

[14]  H. Urbach,et al.  Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis , 2010, Annals of neurology.

[15]  B. Giometto,et al.  Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia , 2007, Neurology.

[16]  M. Yoneda,et al.  High prevalence of serum autoantibodies against the amino terminal of α-enolase in Hashimoto's encephalopathy , 2007, Journal of Neuroimmunology.

[17]  D. Friedman,et al.  Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen , 2010, The Lancet Neurology.

[18]  M. Fisher.  An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). , 1956, The New England journal of medicine.

[19]  S. Kusunoki,et al.  Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome , 1992, Annals of neurology.

[20]  M. Dalakas,et al.  Brain γ-Aminobutyric Acid Changes in Stiff-Person Syndrome , 2005 .

[21]  T. Walls,et al.  Hashirnoto's encephalopathy , 1991, Neurology.

[22]  B. Sharrack,et al.  Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. , 2003, Brain : a journal of neurology.

[23]  M. Pani,et al.  Familial clustering of juvenile thyroid autoimmunity: higher risk is conferred by human leukocyte antigen DR3-DQ2 and thyroid peroxidase antibody status in fathers. , 2002, The Journal of clinical endocrinology and metabolism.

[24]  K. Ikeda,et al.  Antineuronal antibodies in acute cerebellar ataxia following Epstein‐Barr virus infection , 1994, Neurology.

[25]  J. Dichgans,et al.  Cerebellar ataxia with glutamic acid decarboxylase autoantibodies , 1999, Neurology.

[26]  M. Manto,et al.  [Cerebellar syndrome associated with Hashimoto's encephalopathy]. , 1996, Revue neurologique.

[27]  Loise M. Francisco,et al.  Tumor-specific killer cells in paraneoplastic cerebellar degeneration , 1998, Nature Medicine.

[28]  B. Hart,et al.  Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. , 2010, Seminars in arthritis and rheumatism.

[29]  J. Rose,et al.  Journal of Neuroinflammation Cerebellar Purkinje Cells Incorporate Immunoglobulins and Immunotoxins in Vitro: Implications for Human Neurological Disease and Immunotherapeutics , 2022 .

[30]  F. Udaka,et al.  Miller Fisher-Guillain-Barré overlap syndrome with enhancing lesions in the spinocerebellar tracts. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[31]  D. Sanders,et al.  Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia , 2006, Neurology.

[32]  A. Malaviya,et al.  Cerebellar ataxia in systemic lupus erythematosus: three case reports. , 1988, Annals of the rheumatic diseases.

[33]  D. Drachman,et al.  Ataxia associated with Hashimoto's disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis , 2001, Journal of neurology, neurosurgery, and psychiatry.

[34]  L. Ramió-Torrentá,et al.  Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. , 2008, Brain : a journal of neurology.

[35]  J. Dichgans,et al.  The humoral response in the pathogenesis of gluten ataxia , 2002, Neurology.

[36]  G. E. Newman,et al.  Incidence and significance , 1988 .

[37]  P. Chattopadhyay,et al.  Acute cerebellar ataxia in lupus , 2011, Lupus.

[38]  R. Darnell,et al.  Paraneoplastic syndromes involving the nervous system. , 2003, The New England journal of medicine.

[39]  J. Hunter,et al.  Cerebral and Cerebellar Volume Loss in Children and Adolescents with Systemic Lupus Erythematosus: A Review of Clinically Acquired Brain Magnetic Resonance Imaging , 2010, The Journal of Rheumatology.

[40]  M. Dalakas,et al.  Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies , 2006, Neurology.

[41]  E. Richardson,et al.  The neurological manifestations of systemic lupus erythematosus. , 1968, Medicine.

[42]  J. Bobholz,et al.  Multiple Sclerosis and Other Demyelinating Disorders , 2011 .

[43]  M. Manto,et al.  Syndrome cérébelleux associé à une encéphalopathie d'hashimoto. , 1996 .

[44]  L. Cinotti,et al.  FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. , 2004, Brain : a journal of neurology.

[45]  C. Almonte,et al.  [Acute cerebellitis]. , 1962, Revista chilena de pediatria.

[46]  D. Jacobowitz,et al.  Stiff person syndrome: Advances in pathogenesis and therapeutic interventions , 2001, Neurology.

[47]  L. Borges,et al.  Intraneuronal accumulation of myeloma proteins. , 1985, Archives of neurology.

[48]  A. Vincent,et al.  Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia , 2010, Brain : a journal of neurology.

[49]  J. J. Stagnone,et al.  Small bowel changes in dermatitis herpetiformis. , 1969, Southern medical journal.

[50]  M. Rosenblum,et al.  Paraneoplastic cerebellar degeneration. , 1992, Neurology.

[51]  G. Davies-Jones,et al.  Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia , 1998, The Lancet.

[52]  H. Meinck,et al.  Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia , 2013, Journal of Neuroinflammation.

[53]  J. Honnorat,et al.  Spectrum of paraneoplastic disease associated with lymphoma , 2011, Neurology.

[54]  F. Ducray,et al.  Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience , 2014, European journal of neurology.

[55]  R. Casamitjana,et al.  T‐cell reactivity to glutamic acid decarboxylase in stiff‐man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity , 2002, Clinical and experimental immunology.

[56]  Yasuhiro Kagamihara,et al.  Quantitative evaluation of movement disorders in neurological diseases based on EMG signals , 2008, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[57]  B. Dan,et al.  Opsoclonus-myoclonus associated with celiac disease. , 2006, Pediatric neurology.

[58]  I. Korponay-Szabó,et al.  Deamidated Gliadin Peptides Form Epitopes That Transglutaminase Antibodies Recognize , 2008, Journal of pediatric gastroenterology and nutrition.

[59]  J. Honnorat,et al.  Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats , 2013, Orphanet Journal of Rare Diseases.

[60]  R. Balice-Gordon,et al.  Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series , 2010, The Lancet Neurology.

[61]  P. Ranganathan,et al.  An unusual case of cerebellar hemorrhage in a patient with systemic lupus erythematosus , 2010, Arthritis care & research.

[62]  H. Mitoma,et al.  Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies , 2008, Journal of the Neurological Sciences.

[63]  E. Anghileri,et al.  Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach , 2008, Journal of Neuroimmunology.

[64]  Xiaoyu Peng,et al.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies , 2008, The Lancet Neurology.

[65]  J. Dichgans,et al.  Cerebellar encephalitis in adults , 2004, Journal of Neurology.

[66]  W. Paulus,et al.  Hashimoto encephalopathy: A brainstem vasculitis? , 2000, Neurology.

[67]  M. Suenaga,et al.  Acute cerebellar ataxia of a patient with SLE , 2000, Clinical neurology and neurosurgery (Dutch-Flemish ed. Print).

[68]  C. Wessig,et al.  Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. , 2010, Brain : a journal of neurology.

[69]  D. Ellison,et al.  Cerebellum and brainstem vasculopathy in systemic lupus erythematosus: two clinico-pathological cases. , 1994, Annals of the rheumatic diseases.

[70]  S. Tsuji,et al.  Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration , 1994, Journal of the Neurological Sciences.

[71]  M. Yoneda,et al.  Hashimoto’s encephalopathy presenting with progressive cerebellar ataxia , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[72]  S. Baekkeskov,et al.  Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[73]  R. Kalb,et al.  AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location , 2009, Annals of neurology.

[74]  W. Cooke,et al.  Neurological disorders associated with adult coeliac disease. , 1966, Brain : a journal of neurology.

[75]  R. Griffey,et al.  Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. , 1989, Annals of the rheumatic diseases.

[76]  D. Copenhagen,et al.  The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[77]  P. De Camilli,et al.  Association of HLA-DQB1*0201 with stiff-man syndrome. , 1993, The Journal of clinical endocrinology and metabolism.

[78]  J. Li,et al.  Antecedent infections in Fisher syndrome , 2005, Neurology.

[79]  R. Richter.  PRESIDENTIAL ADDRESS: The Ataxic Form of Polyradiculoneuritis (Landry‐Guillain‐Barré Syndrome) Clinical and Pathologic Observations , 1962, Journal of neuropathology and experimental neurology.

[80]  L. Trandafir,et al.  Celiac disease with neurologic manifestations in children. , 2013, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.

[81]  D. Perani,et al.  Human Stiff-Person Syndrome IgG Induces Anxious Behavior in Rats , 2011, PloS one.

[82]  A. Vincent,et al.  Stiff, twitchy or wobbly: are GAD antibodies pathogenic? , 2008, Brain : a journal of neurology.

[83]  I. Kanazawa,et al.  Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: Clinical and immunohistochemical studies , 2011, Neurology.

[84]  J. Whisstock,et al.  GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop , 2007, Nature Structural &Molecular Biology.

[85]  M. Dalakas,et al.  The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome , 2000, Neurology.

[86]  D. Aeschlimann,et al.  Protein Crosslinking in Assembly and Remodelling of Extracellular Matrices: The Role of Transglutaminases , 2000, Connective tissue research.

[87]  S. Rogers,et al.  Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site , 1995, Neuron.

[88]  G. Davies-Jones,et al.  The humoral response in the pathogenesis of gluten ataxia , 2002, Neurology.

[89]  Jianning Wei,et al.  Demonstration of functional coupling between γ-aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[90]  D. Sanders,et al.  Transglutaminase 6 antibodies in the diagnosis of gluten ataxia , 2013, Neurology.

[91]  M. Ikawa,et al.  Hashimoto’s Encephalopathy as a Treatable Adult-Onset Cerebellar Ataxia Mimicking Spinocerebellar Degeneration , 2012, European Neurology.

[92]  S. Tsuji,et al.  Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss , 1995, Clinical Neurology and Neurosurgery.

[93]  A. Vincent,et al.  Autoimmune encephalitis -- new awareness, challenging questions. , 2011, Discovery medicine.

[94]  L. Lagae,et al.  MRI findings in acute cerebellitis , 2004, European Radiology.

[95]  I. N. Reid,et al.  Hashimoto’s encephalopathy , 2003, Neurology.

[96]  D. Sanders,et al.  Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase , 2008, Annals of neurology.

[97]  H. Willison,et al.  Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significance , 2001, Journal of Neuroimmunology.

[98]  M. Erlander,et al.  Two genes encode distinct glutamate decarboxylases , 1991, Neuron.

[99]  H. Greenberg.  Paraneoplastic cerebellar degeneration , 2004, Journal of Neuro-Oncology.

[100]  L. Brain,et al.  Hashimoto's disease and encephalopathy. , 1966, Lancet.

[101]  E. Tolosa,et al.  Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity , 1997, Neurology.

[102]  A. Connolly,et al.  Course and outcome of acute cerebellar ataxia , 1994, Annals of neurology.

[103]  S. Nakanishi,et al.  Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. , 2000, The New England journal of medicine.

[104]  P. Shaw,et al.  Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers--report of 5 cases. , 1991, Neurology.

[105]  H. Mitoma,et al.  Dual impairment of GABAA- and GABAB-receptor-mediated synaptic responses by autoantibodies to glutamic acid decarboxylase , 2003, Journal of the Neurological Sciences.

[106]  C. Geis,et al.  Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats , 2013, Experimental Neurology.

[107]  H. Mitoma,et al.  Classification of cerebellar atrophy using voxel-based morphometry and SPECT with an easy Z-score imaging system. , 2010, Internal medicine.

[108]  S. Maekawa,et al.  Interaction of NAP-22 with brain glutamic acid decarboxylase (GAD) , 2013, Neuroscience Letters.

[109]  H. Willison,et al.  Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. , 2009, Investigative ophthalmology & visual science.

[110]  Xiaoyu Peng,et al.  Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis , 2010, The Journal of Neuroscience.

[111]  A. Feinstein,et al.  I. Incidence and Significance ‡ , 1961, The Yale journal of biology and medicine.

[112]  Jianjun Li,et al.  A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. , 2007, Biochemistry.

[113]  M. Daras,et al.  Cerebellar ataxia in systemic lupus erythematosus. , 1983, New York state journal of medicine.

[114]  M. Rowley,et al.  HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin-dependent diabetes mellitus patients. , 1993, Human immunology.

[115]  J. Honnorat,et al.  Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration. , 2012, Neuro-oncology.

[116]  A. Draguhn,et al.  GABA Metabolism and Transport: Effects on Synaptic Efficacy , 2012, Neural plasticity.

[117]  S. Tsuji,et al.  Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice , 1995, Clinical Neurology and Neurosurgery.

[118]  I. Wilkinson,et al.  Should we be ‘nervous’ about coeliac disease? Brain abnormalities in patients with coeliac disease referred for neurological opinion , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[119]  H. Mitoma,et al.  Low-Titer Anti-GAD-Antibody-Positive Cerebellar Ataxia , 2013, The Cerebellum.

[120]  T. Miyatake,et al.  Association of IgG anti‐GD1a antibody with severe Guillain–Barré syndrome , 1993, Muscle & nerve.

[121]  H. Brashear,et al.  Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma , 1983, Annals of neurology.

[122]  H. Mitoma,et al.  Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[123]  K. Hirata,et al.  Ataxic Guillain‐Barré syndrome with anti‐GQ1b antibody: Relation to Miller Fisher syndrome , 2000, Neurology.

[124]  S. Currie,et al.  Progressive ataxia with palatal tremor due to gluten sensitivity , 2012, Movement disorders : official journal of the Movement Disorder Society.

[125]  Josep Dalmau,et al.  Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma , 2007, Annals of neurology.

[126]  J. Delgado-García,et al.  The GABAergic septohippocampal pathway is directly involved in internal processes related to operant reward learning. , 2014, Cerebral cortex.

[127]  B. Passarella,et al.  Cerebellar subacute syndrome due to corticosteroid-responsive encephalopathy associated with autoimmune thyroiditis (also called "Hashimoto's encephalopathy"). , 2005, La Clinica terapeutica.

[128]  N. Kokubun,et al.  Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[129]  J. Dichgans,et al.  Effectiveness of intravenous immunoglobin therapy in cerebellar ataxia associated with gluten sensitivity , 2001, Annals of neurology.

[130]  S. Baekkeskov,et al.  Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain , 1992, The Journal of cell biology.

[131]  M. Paulsson,et al.  Epidermal Transglutaminase (TGase 3) Is the Autoantigen of Dermatitis Herpetiformis , 2002, The Journal of experimental medicine.

[132]  David W. Franklin,et al.  Computational Mechanisms of Sensorimotor Control , 2011, Neuron.

[133]  K. Hirata,et al.  Ataxic Guillain–Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[134]  P. De Camilli,et al.  GABA and pancreatic beta‐cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic‐like microvesicles suggests their role in GABA storage and secretion. , 1991, The EMBO journal.

[135]  M. Yamashita,et al.  Autoantibodies against the amino terminal of α-enolase are a useful diagnostic marker of Hashimoto's encephalopathy , 2005, Journal of Neuroimmunology.

[136]  H. Meinck,et al.  Inhibition of γ‐aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff‐man syndrome , 1998 .

[137]  T. Miyatake,et al.  Beneficial effect of plasmapheresis on Fisher's syndrome. , 1993, Muscle & nerve.

[138]  A. Vincent,et al.  Immunization against GAD Induces Antibody Binding to GAD-Independent Antigens and Brainstem GABAergic Neuronal Loss , 2013, PloS one.

[139]  N. Yuki,et al.  Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis , 1999, Annals of neurology.

[140]  C. Vedeler,et al.  Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies , 2009, Acta neurologica Scandinavica.

[141]  N. Yuki,et al.  IgG anti-GQ1b positive acute ataxia without ophthalmoplegia , 1999, Journal of neurology, neurosurgery, and psychiatry.

[142]  D. Copenhagen,et al.  The role of the synthetic enzyme GAD65 in the control of neuronal γ-aminobutyric acid release , 1999 .

[143]  M. J. van den Bent,et al.  Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. , 2003, Brain : a journal of neurology.

[144]  D. Sanders,et al.  Myoclonus ataxia and refractory coeliac disease , 2014, Cerebellum & Ataxias.

[145]  L. Velloso,et al.  GAD Autoantibodies in IDDM, Stiff-Man Syndrome, and Autoimmune Polyendocrine Syndrome Type I Recognize Different Epitopes , 1994, Diabetes.

[146]  J. McNamara,et al.  Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. , 1994, Science.

[147]  M. Molinari,et al.  Cerebellar contribution to feedforward control of locomotion , 2014, Front. Hum. Neurosci..

[148]  Winfried Stöcker,et al.  Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia , 2014, Journal of Neuroinflammation.

[149]  Yasuhiro Kagamihara,et al.  The Functional Role of the Cerebellum in Visually Guided Tracking Movement , 2012, The Cerebellum.

[150]  G. Davies-Jones,et al.  Dietary treatment of gluten ataxia , 2003, Journal of neurology, neurosurgery, and psychiatry.

[151]  J. Dalmau,et al.  Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. , 2014, JAMA neurology.

[152]  J. Hildebrand,et al.  Subacute pancerebellar syndrome associated with systemic lupus erythematosus , 1996, Clinical Neurology and Neurosurgery.

[153]  Adam Possner,et al.  Cerebellum , 2012, Neurology.

[154]  L. Sollid,et al.  Role of tissue transglutaminase in celiac disease. , 2000, Journal of pediatric gastroenterology and nutrition.

[155]  J. Dichgans,et al.  Manifestation of Hashimoto’s Encephalopathy Years before Onset of Thyroid Disease , 1999, European Neurology.

[156]  J. Murray.  Gluten sensitivity: from gut to brain , 2011 .

[157]  J. Honnorat,et al.  Effects of anti–glutamic acid decarboxylase antibodies associated with neurological diseases , 2007, Annals of neurology.

[158]  H. Mitoma,et al.  Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia. , 2009, Internal medicine.

[159]  J. Honnorat,et al.  Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia , 2011, Orphanet journal of rare diseases.